Journal of Multidisciplinary Applied Natural Science
Open Access Journal
Scopus CiteScore 2024
4.8
Calculated on 05 May, 2025
SJR 2024
0.31
Powered by scimagojr.com
Open Access Journal
4.8
Calculated on 05 May, 2025
0.31
Powered by scimagojr.com
https://doi.org/10.47352/jmans.2774-3047.285
Saurabh Kumar Banerjee
Moon Moon Lahiri
Devika Agarwal
Happy Agrawal
Access to quality and affordable generic medicines is vital to address the challenging situation which the country is currently facing in the present context. Less than 50% of medications are prescribed in India under their generic (INPN) names, despite the country being one of the leading suppliers of generic medications globally. Up to 90% of the money that impoverished people spend on healthcare can be attributed to medications. Thus, affordability of medications is essential for achieving desired treatment outcome since high drug costs lead to a reduction in access to healthcare. There is a lack of scientific data concerning the understanding of generic medicines among various stakeholders, including physicians, pharmacists, the general public, and health policy advocates, hence a need was felt to do an in-depth introspection of the scientific data centered around awareness and affordability of generic medicines in India and propose a conceptual framework for developing a strategic roadmap for popularizing generic medicines in India. Extensive literature search of research papers with high citations published between 2011–2024 were retrieved and investigated using PRISMA 2020 Flow diagram. In context to physicians the study suggested that physicians should choose less expensive brands of antibiotics and there is a need to design interventions at the fresh graduate level at medical colleges centered around the efficacy of generic drugs over the branded drugs. In context to Govt health policymakers the study suggested that policies towards opening Fair Price Medicine Shop (FPMS) taking the Government of West Bengal model could be taken into consideration and Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP) drug policies on medicine distribution and procurement must be revisited with reference to the NELM. In context to pharmacists, community chemists regulatory agencies and educational institutions should work together to raise the level of generic drugs expertise among community chemists and drug store employees. Finally in context to patients, patient centric educational and awareness programs should be developed at the primary care level related to awareness and misconceptions of generic drugs in the public.
[1] V. Roy and P. Rana. (2018). "Prescribing generics: All in a name". Indian Journal of Medical Research. 147 (5): 442-444. 10.4103/ijmr.IJMR_1940_17.
DOI: https://doi.org/10.4103/ijmr.IJMR_1940_17[2] R. J. Desai, A. Sarpatwari, S. Dejene, N. F. Khan, J. Lii, J. R. Rogers, S. K. Dutcher, S. Raofi, J. Bohn, J. G. Connolly, M. A. Fischer, A. S. Kesselheim, and J. J. Gagne. (2019). "Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims". PLoS Medicine. 16 (3): e1002763. 10.1371/journal.pmed.1002763.
DOI: https://doi.org/10.1371/journal.pmed.1002763[3] R. Ofori-Asenso. (2016). "A closer look at the World Health Organization's prescribing indicators". Journal of Pharmacology and Pharmacotherapeutics. 7 (1): 51-4. 10.4103/0976-500X.179352.
DOI: https://doi.org/10.4103/0976-500X.179352[4] P. R. Shelat and S. K. Kumbar. (2015). "Analysis of Out Door Patients' Prescriptions According to World Health Organization (WHO) Prescribing Indicators Among Private Hospitals in Western India". Journal of Clinical and Diagnostic Research. 9 (3): FC01-4. 10.7860/JCDR/2015/12724.5632.
DOI: https://doi.org/10.7860/JCDR/2015/12724.5632[5] R. Meenakshi, N. Selvaraj, N. Anandabaskar, A. Dhamodharan, A. K. Badrinath, and M. A. Rajamohammad. (2022). "Prescription audit of a teaching hospital in South India using World Health Organization core prescribing indicators - A cross-sectional study". Perspectives in Clinical Research. 13 (3): 132-136. 10.4103/picr.PICR_172_20.
DOI: https://doi.org/10.4103/picr.PICR_172_20[6] R. Pulcini, S. D'Agostino, M. Dolci, A. Bissioli, L. Caporaso, and F. Iarussi. (2022). "The Impact of COVID-19 on Oral Cancer Diagnosis: A Systematic Review". Journal of Multidisciplinary Applied Natural Science. 2 (2): 65-69. 10.47352/jmans.2774-3047.110.
DOI: https://doi.org/10.47352/jmans.2774-3047.110[7] S. Hussain, S. S. Yadav, K. K. Sawlani, and S. Khattri. (2018). "Assessment of drug prescribing pattern using world health organization indicators in a tertiary care teaching hospital". Indian Journal of Public Health. 62 (2): 156-158. 10.4103/ijph.IJPH_429_16.
DOI: https://doi.org/10.4103/ijph.IJPH_429_16[8] R. P. Priyadharsini, K. Ramasamy, and S. Amarendar. (2022). "Antibiotic-prescribing pattern in the outpatient departments using the WHO prescribing indicators and AWaRe assessment tool in a tertiary-care hospital in South India". Journal of Family Medicine and Primary Care. 11 (1): 74-78. 10.4103/jfmpc.jfmpc_527_21.
DOI: https://doi.org/10.4103/jfmpc.jfmpc_527_21[9] R. B. Hadia, D. B. Joshi, K. H. Gohel, and N. Khambhati. (2022). "Knowledge, attitude, and practice of generic medicines among physicians at multispecialty hospital: An observational study". Perspectives in Clinical Research. 13 (3): 155-160. 10.4103/picr.PICR_281_20.
DOI: https://doi.org/10.4103/picr.PICR_281_20[10] S. Chenchula, R. Gupta, S. K. Gupta, R. Padmavathi, and S. Pathan. (2022). "Assessment of WHO core drug use indicators at a tertiary care Institute of National importance in India". Bioinformation. 18 (10): 888-893. 10.6026/97320630018888.
DOI: https://doi.org/10.6026/97320630018888[11] T. Singh, B. Banerjee, S. Garg, and S. Sharma. (2019). "A prescription audit using the World Health Organization-recommended core drug use indicators in a rural hospital of Delhi". Journal of Education and Health Promotion. 8: 37. 10.4103/jehp.jehp_90_18.
DOI: https://doi.org/10.4103/jehp.jehp_90_18[12] M. Ambade, R. Sarwal, N. Mor, R. Kim, and S. V. Subramanian. (2022). "Components of Out-of-Pocket Expenditure and Their Relative Contribution to Economic Burden of Diseases in India". JAMA Network Open. 5(5): e2210040. 10.1001/jamanetworkopen.2022.10040.
DOI: https://doi.org/10.1001/jamanetworkopen.2022.10040[13] D. K. Meena and M. Jayanthi. (2021). "Cost Analysis of Different Antibiotic Brands Available in Indian Market with Reference to National List of Essential Medicines". Indian Journal of Community Medicine. 46 (1): 93-96. 10.4103/ijcm.IJCM_296_20.
DOI: https://doi.org/10.4103/ijcm.IJCM_296_20[14] K. Mukherjee. (2017). "A Cost Analysis of the Jan Aushadhi Scheme in India". International Journal of Health Policy and Management. 6 (5): 253-256. 10.15171/ijhpm.2017.02.
DOI: https://doi.org/10.15171/ijhpm.2017.02[15] M. Das, S. Choudhury, S. Maity, A. Hazra, T. Pradhan, A. Pal, and R. K. Roy. (2017). "Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department". Journal of Natural Science, Biology and Medicine. 8 (1): 26-31. 10.4103/0976-9668.198351.
DOI: https://doi.org/10.4103/0976-9668.198351[16] S. C. Basak and D. Sathyanarayana. (2012). "Exploring knowledge and perceptions of generic medicines among drug retailers and community pharmacists". Indian Journal of Pharmaceutical Sciences. 74 (6): 571-5. 10.4103/0250-474X.110611.
DOI: https://doi.org/10.4103/0250-474X.110611[17] J. Charan, D. Saxena, M. Chaudhari, S. Dutta, R. J. Kaur, and P. Bhardwaj. (2020). "Opinion of patients seeking primary care regarding prescription of generic drugs: A cross-sectional study". Journal of Family Medicine and Primary Care. 9 (11): 5725-5730. 10.4103/jfmpc.jfmpc_1694_20.
DOI: https://doi.org/10.4103/jfmpc.jfmpc_1694_20[18] V. L. Chaudhari, S. N. Mali, A. V. Dawari, and T. B. Nishandar. (2017). "Awareness about rational use of medicines among fresh Bachelor of Medicine and Bachelor of Surgery graduates". Journal of Education and Health Promotion. 6 : 94. 10.4103/jehp.jehp_59_17.
DOI: https://doi.org/10.4103/jehp.jehp_59_17[19] S. Lavtepatil and S. Ghosh. (2022). "Improving access to medicines by popularising generics: a study of 'India's People's Medicine' scheme in two districts of Maharashtra". BMC Health Services Research. 22 (1): 643. 10.1186/s12913-022-08022-1.
DOI: https://doi.org/10.1186/s12913-022-08022-1[20] P. K. Aivalli, M. A. Elias, M. K. Pati, S. Bhanuprakash, C. Munegowda, Z. C. Shroff, and P. N. Srinivas. (2017). "Perceptions of the quality of generic medicines: implications for trust in public services within the local health system in Tumkur, India". BMJ Global Health. 2 (Suppl 3): e000644. 10.1136/bmjgh-2017-000644.
DOI: https://doi.org/10.1136/bmjgh-2017-000644